Discovery of New Azaindole Metallo-Deubiquitinase CSN5 Inhibitors

CSN5 is responsible for the deneddylation of cullin-RING E3 ubiquitin ligases and is closely linked to the development of various cancers. We previously developed a noncatalytic activity assay platform using novel fluorescent probes derived from azaindole inhibitors, which also highlighted the potential for further structural optimization of azaindoles. Herein, we report a series of new 4-NH-substituted azaindole derivatives, some of which showed nanomolar activity against the CSN5 subunit. Cellular assays revealed that the new azaindoles increase the cullin 1 neddylation in cancer cells. Importantly, they exhibit synergistic anticancer effects in combination with poly(ADP-ribose) polymerase inhibitors through increasing DNA damage. This work presents a new lead compound and a potential combination strategy for drug discovery targeting CSN5.

Authors

Institutions

Publication Details

Journal
Journal of Medicinal Chemistry
Published
2025-03-07
DOI
https://doi.org/10.1021/acs.jmedchem.5c00184
Citations
2
Primary Topic
Research on Leishmaniasis Studies
Type
article
Field-Weighted Citation Impact
3.76

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Discovery of New Azaindole Metallo-Deubiquitinase CSN5 Inhibitors

Ruisheng Xiong, Guo‐Bo Li, Lingling Yang, Jingwei Wu et al.
2 citations
Journal of Medicinal Chemistry
Research on Leishmaniasis Studies
3.76
article

Discovery of New Azaindole Metallo-Deubiquitinase CSN5 Inhibitors

Ruisheng Xiong, Guo‐Bo Li, Lingling Yang, Jingwei Wu, Yingying Jiang, Hui Lei, Pengcheng Lei, Yu‐Hang Yan, Weifeng Zhang, Wenyi Liu, Yanjun Wang, Zhiwen Yang, Hang Zhang, Jianlin Deng
article en
2 citations

Abstract

CSN5 is responsible for the deneddylation of cullin-RING E3 ubiquitin ligases and is closely linked to the development of various cancers. We previously developed a noncatalytic activity assay platform using novel fluorescent probes derived from azaindole inhibitors, which also highlighted the potential for further structural optimization of azaindoles. Herein, we report a series of new 4-NH-substituted azaindole derivatives, some of which showed nanomolar activity against the CSN5 subunit. Cellular assays revealed that the new azaindoles increase the cullin 1 neddylation in cancer cells. Importantly, they exhibit synergistic anticancer effects in combination with poly(ADP-ribose) polymerase inhibitors through increasing DNA damage. This work presents a new lead compound and a potential combination strategy for drug discovery targeting CSN5.

Journal of Medicinal ChemistryVol. 68(6)
Xihua University (CN), Ministry of Education of the People's Republic of China (CN), Sichuan University (CN), Bioengineering Center (RU)
National Natural Science Foundation of China, Department of Science and Technology of Sichuan Province, Sichuan University, National Key Research and Development Program of China
Openalex Percentile: Top 9%
Research on Leishmaniasis Studies
3.76
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.